Clinical Trials Browser

Phase NA × pembrolizumab × CNS × Clear all

NCT02658279 2026-03-03

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

Phase NA Active not recruiting

Glioma